Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.35+0.10 (+1.21%)
Close on Nov 13, 2026Market cap $3.13BP/E –Yield –
Bausch Health Companies enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bausch Health Companies's enterprise value was $23.01B on Nov 11, 2026, against $23.01B a year earlier. Over the last 5 years it ranged from $22.06B to $31.65B, with a median of $24.11B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $23.01B | -1.0% |
| 2025 | Dec 31, 2025 | $23.23B | -5.9% |
| 2024 | Dec 31, 2024 | $24.68B | -3.4% |
| 2023 | Dec 29, 2023 | $25.54B | +6.6% |
| 2022 | Dec 30, 2022 | $23.96B | -24.3% |
| 2021 | Dec 31, 2021 | $31.65B | +2.7% |
| 2020 | Dec 31, 2020 | $30.82B | -7.6% |
| 2019 | Dec 31, 2019 | $33.36B | +10.1% |
| 2018 | Dec 31, 2018 | $30.30B | -9.6% |
| 2017 | Dec 29, 2017 | $33.52B | -4.1% |
| 2016 | Dec 30, 2016 | $34.94B | -45.8% |
| 2015 | Dec 31, 2015 | $64.46B | +1.7% |
| 2014 | Dec 31, 2014 | $63.38B | +13.2% |
| 2013 | Dec 31, 2013 | $55.99B | +119.8% |
| 2012 | Dec 31, 2012 | $25.48B | +32.1% |
| 2011 | Dec 30, 2011 | $19.29B | +75.6% |
| 2010 | Dec 31, 2010 | $10.99B | +130.8% |
| 2009 | Dec 31, 2009 | $4.76B | – |
See a number that looks wrong?